Biotage AB Asset Resilience Ratio
Biotage AB asset resilience ratio. Biotage AB (BIOT) has an Asset Resilience Ratio of 8.92% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Biotage AB (BIOT) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Biotage AB (2000–2024)
Asset resilience ratio of Biotage AB from 2000 to 2024. This chart shows how Biotage AB's Asset Resilience Ratio has changed over time. See BIOT FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Biotage AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BIOT total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr420.00 Million | 8.92% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr420.00 Million | 8.92% |
Asset Resilience Insights
- Limited Liquidity: Biotage AB maintains only 8.92% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Biotage AB Industry Peers by Asset Resilience Ratio
Compare Biotage AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
Biotage AB Asset Resilience Ratio by Year (2000–2024)
Biotage AB asset resilience ratio by year from 2000 to 2024. The table below shows the annual Asset Resilience Ratio data for Biotage AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 8.50% | Skr434.00 Million ≈ $46.71 Million |
Skr5.10 Billion ≈ $549.27 Million |
-3.46pp |
| 2023-12-31 | 11.97% | Skr590.00 Million ≈ $63.49 Million |
Skr4.93 Billion ≈ $530.65 Million |
-6.89pp |
| 2022-12-31 | 18.85% | Skr441.00 Million ≈ $47.46 Million |
Skr2.34 Billion ≈ $251.71 Million |
+3.44pp |
| 2021-12-31 | 15.41% | Skr307.00 Million ≈ $33.04 Million |
Skr1.99 Billion ≈ $214.37 Million |
-10.35pp |
| 2020-12-31 | 25.76% | Skr369.49 Million ≈ $39.76 Million |
Skr1.43 Billion ≈ $154.37 Million |
+11.99pp |
| 2019-12-31 | 13.77% | Skr183.87 Million ≈ $19.79 Million |
Skr1.34 Billion ≈ $143.74 Million |
-3.69pp |
| 2018-12-31 | 17.46% | Skr175.17 Million ≈ $18.85 Million |
Skr1.00 Billion ≈ $107.96 Million |
-5.37pp |
| 2017-12-31 | 22.83% | Skr172.86 Million ≈ $18.60 Million |
Skr757.20 Million ≈ $81.49 Million |
+4.72pp |
| 2016-12-31 | 18.11% | Skr125.88 Million ≈ $13.55 Million |
Skr695.20 Million ≈ $74.81 Million |
+10.50pp |
| 2008-12-31 | 7.61% | Skr98.80 Million ≈ $10.63 Million |
Skr1.30 Billion ≈ $139.79 Million |
-2.97pp |
| 2002-12-31 | 10.57% | Skr71.70 Million ≈ $7.72 Million |
Skr678.04 Million ≈ $72.97 Million |
-12.34pp |
| 2001-12-31 | 22.91% | Skr194.03 Million ≈ $20.88 Million |
Skr846.82 Million ≈ $91.13 Million |
-15.89pp |
| 2000-12-31 | 38.81% | Skr370.00 Million ≈ $39.82 Million |
Skr953.47 Million ≈ $102.61 Million |
-- |
About Biotage AB
Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation produ… Read more